Takeda Canada Inc., the Canadian organization of Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that non-profit ...
NET PROFIT FORECAST: Takeda is expected to post a 59% drop in net profit to 43.58 billion yen, equivalent to $280.2 million, for the three months ended Dec. 31, according to a poll of analysts by data ...
Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and ...
Takeda Pharmaceutical Co. will get to arbitrate claims by a plaintiff that accused the company of delaying the generic ...
Neurocrine Biosciences, Inc., is a leading neuroscience-focused, biopharmaceutical company, announced it has amended its agreement with Takeda to develop and commercialize osavampator (NBI-1065845/TAK ...
Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...
Weekly magazine Shukan Bunshun corrected a key part of its initial scoop on the “trouble” between celebrity Masahiro Nakai ...
Mizuho Securities analyst Uy Ear has maintained their neutral stance on NBIX stock, giving a Hold rating on January 21.Invest with Confidence: ...
Neurocrine Biosciences begins phase 3 registrational study of osavampator as an adjunctive therapy to treat major depressive disorder: San Diego Wednesday, January 29, 2025, 18:00 ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
In a step towards developing advanced materials for functional coatings, a research group from Japan, developed a technology ...
Buy and Sell Signals for Takeda Pharmaceutical Company Limited American Depositary Shares (each Representing 1/2 Of A Share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback